Works matching AU Cusmai, Antonio

Results: 20

Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7441, doi. 10.3390/jcm13237441

By:

Fedele, Palma;
Landriscina, Matteo;
Moraca, Lucia;
Gadaleta-Caldarola, Arianna;
Cusmai, Antonio;
Giuliani, Francesco;
Chiuri, Vincenzo;
Giotta, Francesco;
Pinto, Antonello;
Mirisola, Valentina;
Gadaleta-Caldarola, Gennaro

Publication type:

Article

Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis.

Published in:

Cells (2073-4409), 2022, v. 11, n. 12, p. 1857, doi. 10.3390/cells11121857

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Massafra, Raffaella;
Bove, Samantha;
Comes, Maria Colomba;
Fanizzi, Annarita;
Rinaldi, Lucia;
Acquafredda, Silvana;
Gadaleta-Caldarola, Gennaro;
Oreste, Donato;
Zito, Alfredo;
Giotta, Francesco;
Lorusso, Vito;
Palmiotti, Gennaro

Publication type:

Article

Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy.

Published in:

Pharmaceutics, 2024, v. 16, n. 9, p. 1146, doi. 10.3390/pharmaceutics16091146

By:

Pinto, Antonello;
Guarini, Chiara;
Giampaglia, Marianna;
Sanna, Valeria;
Melaccio, Assunta;
Lanotte, Laura;
Santoro, Anna Natalizia;
Pini, Francesca;
Cusmai, Antonio;
Giuliani, Francesco;
Gadaleta-Caldarola, Gennaro;
Fedele, Palma

Publication type:

Article

Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress.

Published in:

Current Oncology, 2022, v. 29, n. 10, p. 7925, doi. 10.3390/curroncol29100626

By:

Gadaleta-Caldarola, Gennaro;
Rizzo, Alessandro;
Dadduzio, Vincenzo;
Lombardi, Lucia;
Gadaleta-Caldarola, Arianna;
Infusino, Stefania;
Cusmai, Antonio;
Citrigno, Claudia;
Palmiotti, Gennaro

Publication type:

Article

Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future.

Published in:

Current Oncology, 2022, v. 29, n. 2, p. 551, doi. 10.3390/curroncol29020050

By:

Rizzo, Alessandro;
Ricci, Angela Dalia;
Cusmai, Antonio;
Acquafredda, Silvana;
De Palma, Giuseppe;
Brandi, Giovanni;
Palmiotti, Gennaro

Publication type:

Article

The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis.

Published in:

Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 842, doi. 10.3390/jpm12050842

By:

Rizzo, Alessandro;
Santoni, Matteo;
Mollica, Veronica;
Ricci, Angela Dalia;
Calabrò, Concetta;
Cusmai, Antonio;
Gadaleta-Caldarola, Gennaro;
Palmiotti, Gennaro;
Massari, Francesco

Publication type:

Article

Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer.

Published in:

Expert Opinion on Investigational Drugs, 2022, v. 31, n. 7, p. 707, doi. 10.1080/13543784.2022.2078191

By:

Rizzo, Alessandro;
Massafra, Raffaella;
Fanizzi, Annarita;
Rinaldi, Lucia;
Cusmai, Antonio;
Latorre, Agnese;
Zaccaria, Gian Maria;
Ronchi, Maria;
Telegrafo, Michele;
Gadaleta-Caldarola, Gennaro;
Giotta, Francesco;
Lorusso, Vito;
Palmiotti, Gennaro

Publication type:

Article

Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary results, key challenges, and clinical potential.

Published in:

2022

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Acquafredda, Silvana;
Rinaldi, Lucia;
Palmiotti, Gennaro

Publication type:

Editorial

Treatment-related adverse events of first-line immunotherapy versus sorafenib for advanced hepatocellular carcinoma: a meta-analysis.

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 4, p. 323, doi. 10.1080/14740338.2023.2152793

By:

Rizzo, Alessandro;
Carloni, Riccardo;
Ricci, Angela Dalia;
Cusmai, Antonio;
Laforgia, Mariarita;
Calabrò, Concetta;
Ungaro, Valentina;
Oreste, Donato;
Sollitto, Mario;
Palmiotti, Gennaro;
Brandi, Giovanni

Publication type:

Article

Manumycin inhibits farnesyltransferase and induces apoptosis of drug-resistant interleukin 6-producing myeloma cells.

Published in:

British Journal of Haematology, 2002, v. 118, n. 1, p. 157, doi. 10.1046/j.1365-2141.2002.03559.x

By:

Frassanito, Maria Antonia;
Cusmai, Antonio;
Piccoli, Claudia;
Dammacco, Franco

Publication type:

Article

Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward.

Published in:

Medicina (1010660X), 2022, v. 58, n. 5, p. 600, doi. 10.3390/medicina58050600

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Gadaleta-Caldarola, Gennaro;
Palmiotti, Gennaro

Publication type:

Article

Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.

Published in:

Cancers, 2024, v. 16, n. 20, p. 3442, doi. 10.3390/cancers16203442

By:

Fedele, Palma;
Landriscina, Matteo;
Moraca, Lucia;
Cusmai, Antonio;
Gnoni, Antonio;
Licchetta, Antonella;
Guarini, Chiara;
Lanotte, Laura;
Pappagallo, Maria Nicla;
Melaccio, Assunta;
Giordano, Guido;
Maselli, Felicia Maria;
Pinto, Antonello;
Giuliani, Francesco;
Chiuri, Vincenzo;
Giotta, Francesco;
Gadaleta-Caldarola, Gennaro

Publication type:

Article

Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.

Published in:

Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092293

By:

Basso, Umberto;
Paolieri, Federico;
Rizzo, Mimma;
De Giorgi, Ugo;
Bracarda, Sergio;
Antonuzzo, Lorenzo;
Atzori, Francesco;
Cartenì, Giacomo;
Procopio, Giuseppe;
Fratino, Lucia;
D'Arcangelo, Manolo;
Fornarini, Giuseppe;
Zucali, Paolo;
Cusmai, Antonio;
Santoni, Matteo;
Pipitone, Stefania;
Carella, Claudia;
Panni, Stefano;
Deppieri, Filippo Maria;
Zagonel, Vittorina

Publication type:

Article

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.

Published in:

Cancers, 2022, v. 14, n. 6, p. 1404, doi. 10.3390/cancers14061404

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Giovannelli, Francesco;
Acquafredda, Silvana;
Rinaldi, Lucia;
Misino, Andrea;
Montagna, Elisabetta Sara;
Ungaro, Valentina;
Lorusso, Mariagrazia;
Palmiotti, Gennaro

Publication type:

Article

Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers.

Published in:

2022

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Massafra, Raffaella;
Bove, Samantha;
Comes, Maria Colomba;
Fanizzi, Annarita;
Gadaleta-Caldarola, Gennaro;
Oreste, Donato;
Zito, Alfredo;
Giotta, Francesco;
Lorusso, Vito;
Palmiotti, Gennaro

Publication type:

Book Review

Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers.

Published in:

Cancer Control: Journal of the Moffitt Cancer Center, 2022, v. 29, p. 1, doi. 10.1177/10732748221106267

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Massafra, Raffaella;
Bove, Samantha;
Comes, Maria Colomba;
Fanizzi, Annarita;
Gadaleta-Caldarola, Gennaro;
Oreste, Donato;
Zito, Alfredo;
Giotta, Francesco;
Lorusso, Vito;
Palmiotti, Gennaro

Publication type:

Article

Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?

Published in:

Expert Review of Gastroenterology & Hepatology, 2022, v. 16, n. 4, p. 333, doi. 10.1080/17474124.2022.2064273

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Gadaleta-Caldarola, Gennaro;
Palmiotti, Gennaro

Publication type:

Article

Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?

Published in:

2022

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Ricci, Angela Dalia;
Brandi, Giovanni;
Palmiotti, Gennaro

Publication type:

Editorial

Second-line fluoropyrimidine-based doublet chemotherapy for advanced biliary tract cancer: a new standard of care?

Published in:

2022

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Palmiotti, Gennaro

Publication type:

Editorial

Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY.

Published in:

Expert Review of Gastroenterology & Hepatology, 2022, v. 16, n. 3, p. 273, doi. 10.1080/17474124.2022.2047651

By:

Rizzo, Alessandro;
Cusmai, Antonio;
Giovannelli, Francesco;
Acquafredda, Silvana;
Rinaldi, Lucia;
Misino, Andrea;
Palmiotti, Gennaro

Publication type:

Article